151 related articles for article (PubMed ID: 9075737)
1. Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells.
Plymate SR; Bae VL; Maddison L; Quinn LS; Ware JL
Endocrinology; 1997 Apr; 138(4):1728-35. PubMed ID: 9075737
[TBL] [Abstract][Full Text] [Related]
2. Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis.
Plymate SS; Bae VL; Maddison L; Quinn LS; Ware JL
Endocrine; 1997 Aug; 7(1):119-24. PubMed ID: 9449047
[TBL] [Abstract][Full Text] [Related]
3. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen.
Plymate SR; Tennant M; Birnbaum RS; Thrasher JB; Chatta G; Ware JL
J Clin Endocrinol Metab; 1996 Oct; 81(10):3709-16. PubMed ID: 8855827
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
[TBL] [Abstract][Full Text] [Related]
6. EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin.
Maslova K; Kyriakakis E; Pfaff D; Frachet A; Frismantiene A; Bubendorf L; Ruiz C; Vlajnic T; Erne P; Resink TJ; Philippova M
FASEB J; 2015 Feb; 29(2):494-507. PubMed ID: 25381040
[TBL] [Abstract][Full Text] [Related]
7. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.
López-Bermejo A; Buckway CK; Devi GR; Hwa V; Plymate SR; Oh Y; Rosenfeld RG
Endocrinology; 2000 Nov; 141(11):4072-80. PubMed ID: 11089538
[TBL] [Abstract][Full Text] [Related]
8. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium.
Tennant MK; Thrasher JB; Twomey PA; Drivdahl RH; Birnbaum RS; Plymate SR
J Clin Endocrinol Metab; 1996 Oct; 81(10):3774-82. PubMed ID: 8855837
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures.
Quinn LS; Haugk KL
J Cell Physiol; 1996 Jul; 168(1):34-41. PubMed ID: 8647920
[TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R
Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
16. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and -6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid.
Drivdahl RH; Sprenger C; Trimm K; Plymate SR
Endocrinology; 2001 May; 142(5):1990-8. PubMed ID: 11316765
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation.
Damon SE; Maddison L; Ware JL; Plymate SR
Endocrinology; 1998 Aug; 139(8):3456-64. PubMed ID: 9681496
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression.
Cullen KJ; Lippman ME; Chow D; Hill S; Rosen N; Zwiebel JA
Mol Endocrinol; 1992 Jan; 6(1):91-100. PubMed ID: 1310798
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.
Furukawa J; Wraight CJ; Freier SM; Peralta E; Atley LM; Monia BP; Gleave ME; Cox ME
Prostate; 2010 Feb; 70(2):206-18. PubMed ID: 19790231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
